Skip to main content
AMLX logo

AMLX · Amylyx Pharmaceuticals, Inc.

Track AMLX — free
$21.63 -0.85 (-3.78%) At close · Aug 14
Market Cap
$2.41B
Shares
111.42M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-09 GINA MAZZARIELLO 30,000
2026-03-02 Bedrosian Camille L 6,461
2026-03-02 Cohen Joshua B 29,282
2026-03-02 Mazzariello Gina 6,844
2026-03-02 Klee Justin B. 29,282
2026-03-02 Frates James M 7,909
2026-02-23 Mazzariello Gina 3,419
2026-02-02 Cohen Joshua B 15,500
2026-02-02 Frates James M 3,557
2026-02-02 Mazzariello Gina 3,448
2026-02-02 Klee Justin B. 15,500
2026-01-16 JOSHUA COHEN 1,974
2026-01-16 JUSTIN KLEE 1,995
2026-01-15 JUSTIN KLEE 136,193
2026-01-15 JOSHUA COHEN 136,193
2026-01-06 Frates James M 3,326
2026-01-06 Cohen Joshua B 7,715
2026-01-06 Klee Justin B. 7,715
2025-12-01 Bedrosian Camille L 6,580
2025-08-12 GINA MAZZARIELLO 30,000
2024-05-15 GINA MAZZARIELLO 10,455
2023-08-15 GINA MAZZARIELLO 6,164
2023-05-16 JAMES M FRATES 32,500
2023-05-15 PATRICK YERAMIAN 49,579
2023-04-17 Patrick D. Yeramian 49,579
2023-03-16 Justin Bernard Klee 100,000
2023-03-16 James Matthew Frates 32,500
2023-03-16 Patrick D. Yeramian 54,627
2023-03-16 Joshua Barry Cohen 100,000
2023-03-16 George Mclean Milne, Jr. 35,000
Showing 1–30 of 30 filings
Key facts CIK 1658551 CUSIP 03237H101 13F (30d) 199 filings 197 filers Visit website Investor relations